Group A Bridging (n = 111) | Group B VKA (n = 318) | Group C DOAC (n = 351) | OR (95% CI) p-value A-B | OR (95% CI) p-value A-C | OR (95% CI) p-value B-C | |
---|---|---|---|---|---|---|
Major complications | 9 (8.1%) | 8 (2.5%) | 10 (2.8%) | 3.42 (1.29–9.10) 0.019 | 3.01 (1.19–7.61) 0.025 | 1.14 (0.44–2.92) 0.816 |
Major without cerebrovascular accidents | 8 (7.2%) | 5 (1.6%) | 6 (1.7%) | 4.86 (1.56–15.99) 0.006 | 4.466 (1.52–13.67) 0.007 | 1.09 (0.33–3.60) 1.0 |
Major pericardial effusion | 3 (2.7%) | 2 (0.6%) | 3 (0.9%) | 4.39 (0.72–26.62) 0.112 | 3.22 (0.64–16.20) 0.153 | 1.36 (0.23–8.20) 1.0 |
Major vascular | 3 (2.7%) | 3 (0.9%) | 1 (0.3%) | 2.92 (0.58–14.67) 0.182 | 9.72 (1.00–94.43) 0.045 | 0.30 (0.03–2.90) 0.351 |
Cerebrovascular complications | 1 (0.9%) | 3 (0.9%) | 4 (1.1%) | 0.96 (0.10–9.27) 1.0 | 0.79 (0.09–7.13) 1.0 | 1.21 (0.27–5.45) 1.0 |
Minor complications | 9 (8.1%) | 24 (7.5%) | 26 (7.4%) | 1.08 (0.49–2.40) 0.838 | 1.10 (0.50–2.43) 0.837 | 0.98 (0.55–1.75) 1.0 |
Minor pericardial effusion | 0 (0.0%) | 4 (1.3%) | 7 (2.0%) | − 0.577 | − 0.204 | 1.60 (0.46–5.51) 0.551 |
Minor vascular complication | 7 (6.3%) | 16 (5.0%) | 17 (4.8%) | 1.27 (0.51–3.17) 0.627 | 1.32 (0.53–3.28) 0.623 | 0.96 (0.48–1.94) 1.0 |
GI haemorrhage | 0 (0.0%) | 1 (0.3%) | 0 (0.0%) | − 0.213 | − 1.0 | − 1.0 |
Groin haemorrhage | 4 (3.6%) | 4 (1.3%) | 3 (0.9%) | 2.94 (0.72–11.94) 0.066 | 4.34 (0.96–19.68) 0.060 | 0.68 (0.15–3.05) 0.714 |
Major | 2 (1.8%) | 0 (0.0%) | 1 (0.3%) | − 0.651 | 3.20 (0.45–23.00) 0.145 | − 0.50 |
Minor | 2 (1.8%) | 4 (1.3%) | 2 (0.6%) | 1.44 (0.26–7.97) 0.019 | 6.42 (0.58–71.51) 0.245 | 0.22 (0.03–2.02) 0.196 |